Skip to main content

Table 2 Oscillation-specific alterations of degree centrality between/among groups

From: Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Node

Slow-5 [mean (SD)]

Slow-4 [mean (SD)]

Slow-3 [mean (SD)]

PD

EPD

MPD

NC

PD

EPD

MPD

NC

PD

EPD

MPD

NC

Put.L

13.99 (5.80)**

12.57 (5.82)

15.13 (5.58)**

10.36 (6.56)

11.13 (5.84)

9.97 (6.07)

12.06 (5.54)

9.24 (5.77)

10.35 (5.99)

8.25 (5.58)

12.01 (5.84)

9.20 (6.00)

Put.R

14.08 (5.85)**

12.55 (5.54)

15.30 (5.85)**

10.45 (6.28)

11.18 (5.89)

10.63 (5.77)

11.61 (6.01)

8.96 (5.78)

10.78 (6.21)

9.04 (5.85)

12.17 (6.19)

9.58 (6.21)

Pall.L

13.59 (6.11)

11.95 (5.71)

14.89 (6.16)**

10.61 (5.56)

13.55 (6.09)

12.54 (4.87)

12.55 (5.77)

11.73 (6.40)

10.16 (5.72)

8.19 (5.41)

11.73 (5.51)

9.60 (6.32)

Pall.R

14.08 (5.96)

13.43 (6.08)

14.59 (5.87)

11.40 (6.31)

12.75 (5.44)

12.54 (4.87)

12.91 (5.90)

11.65 (6.77)

10.14 (5.57)

8.25 (4.49)

11.64 (5.67)

8.85 (5.69)

Thal.L

14.83 (7.44)*

12.94 (7.44)

16.33 (7.15)*

11.05 (7.34)

14.77 (8.26)

13.24 (8.08)

15.98 (8.28)

11.85 (8.44)

11.25 (7.79)

8.86 (7.26)

13.15 (7.74)

8.11 (7.11)

Thal.R

15.11 (7.60)**

13.18 (7.88)

16.65 (7.08)**

10.62 (7.30)

15.54 (8.60)

14.26 (8.65)

16.57 (8.52)

11.59 (7.930

11.65 (7.93)

9.61 (7.77)

13.28 (7.74)

8.49 (7.04)

Accbns.L

10.86 (5.75)

10.06 (5.71)

11.49 (5.77)

9.45 (5.71)

8.75 (5.39)**

8.62 (5.91)

8.84 (5.00)

6.17 (4.17)

5.65 (4.17)

4.13 (3.31)

6.86 (4.42)**##

3.92 (3.41)

Accbns.R

10.94 (6.03)

10.70 (6.40)

11.13 (5.78)

9.69 (5.49)

8.58 (5.19)

8.27 (5.46)

8.83 (5.00)

7.56 (5.89)

5.75 (4.44)

3.93 (3.69)

7.20 (4.48)**##

3.63 (2.94)

F3 t.L

12.43 (6.27)

13.77 (6.09)

11.36 (6.26)

13.63 (7.25)

10.20 (5.17)**

9.59 (4.84)**

10.68 (5.41)*

13.94 (5.64)

11.86 (5.58)

11.73 (5.64)

11.97 (5.58)

14.59 (5.95)

F3 t.R

14.17 (5.84)

14.79 (6.25)

13.68 (5.52)

14.52 (6.83)

13.71 (4.90)

13.51 (4.65)

13.88 (5.14)

14.44 (5.97)

15.29 (5.48)

15.53 (5.98)

15.10 (4.90)

15.46 (5.65)

FMC.L

10.95 (6.30)

10.90 (5.89)

10.99 (6.66)

10.41 (6.42)

9.72 (5.46)

9.81 (5.20)

9.65 (5.70)

7.68 (4.56)

7.97 (5.56)**

8.26 (5.62)

7.75 (5.56)

4.88 (4.25)

FMC.R

10.89 (6.58)

11.46 (6.07)

10.43 (6.98)

11.26 (5.94)

9.49 (5.64)

10.57 (5.57)

8.64 (5.61)

7.37 (5.54)

7.18 (5.19)*

7.97 (5.67)

6.56 (4.74)

4.83 (5.11)

FOC.L

19.08 (4.58)

19.34 (4.28)

18.87 (4.84)

17.74 (5.75)

17.83 (6.10)

17.92 (5.95)

17.75 (6.28)

16.79 (7.05)

16.24 (6.68)

16.92 (6.50)

15.71 (6.83)

14.71 (5.31)

FOC.R

18.35 (5.24)

18.34 (5.34)

18.35 (5.22)

16.48 (6.15)

18.36 (5.64)**

17.50 (5.69)

19.05 (5.56)**

14.60 (6.63)

16.15 (6.35)

16.27 (6.30)

16.06 (6.45)

13.24 (5.97)

T2a.L

11.77 (6.01)

13.27 (6.31)

10.57 (5.53)

12.13 (6.01)

12.88 (5.07)

13.71 (4.94)

12.22 (5.13)

13.30 (5.24)

11.46 (5.95)

13.57 (6.46)

9.78 (4.97)##

11.91 (5.68)

T2a.R

12.38 (5.89)

14.17 (5.47)

10.95 (5.88)

12.16 (6.12)

13.01 (6.14)

13.24 (6.45)

12.83 (5.95)

12.80 (5.62)

12.42 (5.66)

12.84 (5.72)

12.07 (5.66)

11.97 (6.40)

OP.L

9.71 (5.84)**

10.43 (5.89)

9.14 (5.80)**

13.26 (6.29)

9.48 (5.25)*

11.09 (5.15)

8.20 (5.02)**#

12.12 (5.12)

12.58 (5.71)

14.67 (5.80)

10.91 (5.11)**#

15.34 (5.18)

OP.R

9.69 (6.34)*

11.62 (6.39)

8.16 (5.93)**#

12.75 (5.68)

9.09 (5.28)**

10.72 (4.98)

7.80 (5.20)**#

12.10 (5.13)

11.55 (5.63)

14.13 (5.50)

9.51 (4.89)**##

13.40 (5.60)

OLs.L

14.95 (5.41)

15.54 (5.66)

14.48 (5.21)

16.16 (5.46)

17.69 (5.00)

18.69 (4.60)

16.89 (5.21)

19.00 (4.98)

19.95 (4.64)

21.77 (4.15)

18.49 (4.52)**##

21.58 (4.27)

OLs.R

14.70 (5.68)

14.98 (6.19)

14.48 (5.29)

15.11 (5.76)

17.49 (4.50)

17.78 (4.60)

17.26 (4.45)

18.09 (5.11)

19.76 (5.08)

21.46 (4.20)

18.40 (5.35)*#

21.15 (3.87)

  1. Put putamen, Pall pallidum, Thal thalamus, Accbns accumbens, F3 t inferior frontal gyrus, pars triangularis, FMC frontal medial cortex, FOC frontal orbital cortex, T2a middle temporal gyrus, anterior division, OP occipital pole, OLs lateral occipital cortex, superior division, PD Parkinson’s disease, EPD early stage Parkinson’s disease, MPD middle stage Parkinson’s disease, NC normal controls
  2. */**: Comparisons between PD group(s) and normal controls with p < 0.05/p < 0.009, respectively
  3. #/##: Comparisons between PD groups with p < 0.05/p < 0.009, respectively
  4. Of note, only when one of either side node showing a significant difference (p < 0.009) did the contralateral node with p < 0.05 was listed by *(**)/#(##)